Hilde H. Nienhuis

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Journal: Nature medicine

Published: April 02, 2026

Genomic distinctions in adolescent and young adult cancer: A comprehensive review.

Genomic distinctions in adolescent and young adult cancer: A comprehensive review.

Journal: Cancer treatment reviews

Published: July 24, 2025

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Journal: British journal of cancer

Published: June 13, 2025

Clinical implications of whole genome sequencing in metastatic colorectal cancer.

Clinical implications of whole genome sequencing in metastatic colorectal cancer.

Journal: Oncogene

Published: June 10, 2025

Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer.

Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 18, 2025

Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Journal: Nature medicine

Published: February 10, 2025

Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study.

Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study.

Journal: Journal of scleroderma and related disorders

Published: July 05, 2021

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.

Journal: Breast cancer research : BCR

Published: November 09, 2019

Consideration of breast cancer subtype in targeting the androgen receptor.

Consideration of breast cancer subtype in targeting the androgen receptor.

Journal: Pharmacology & therapeutics

Published: September 11, 2018

18F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients.

18F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 27, 2017

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid.

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid.

Journal: Oncotarget

Published: February 16, 2015

Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.

Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 30, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026